Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Merck KGaA Darmstadt Germany
Acquired Company
Silence Therapeutics plc
Description
Merck KGaA, Darmstadt, Germany has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion. This strategic acquisition enhances Merck's capabilities in biotechnology and strengthens its portfolio. The deal is expected to accelerate the development of Silence's innovative therapies. The acquisition agreement reflects Merck's commitment to advancing healthcare solutions.
Fundz sees it the moment Merck KGaA Darmstadt Germany makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Silence Therapeutics plc?
Silence Therapeutics plc was acquired by Merck KGaA Darmstadt Germany, based in Hesse. The deal was reported on October 19, 2026. Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. Merck KGaA Darmstadt Germany is privately held and operates in Manufacturing.
When did Merck KGaA Darmstadt Germany acquire Silence Therapeutics plc?
Merck KGaA Darmstadt Germany's acquisition of Silence Therapeutics plc was reported on October 19, 2026. Merck KGaA, Darmstadt, Germany has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion. This strategic acquisition enhances Merck's capabilities in biotechnology and strengthens its portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Silence Therapeutics plc do?
Silence Therapeutics plc is a biotechnology company specializing in the development of precision engineered medicines. Utilizing its proprietary siRNA technology, the company aims to create innovative therapies for various diseases. It is privately held, operating in Biotechnology, and is based in Greater London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.